Monday, July 12, 2010

Records Live

A drug that is supposed to help with diabetes is in the hot seat right now as the FDA tries to figure out if it should be pulled from the market. The issue is whether or not the drug increases risk of heart attack. What will decide the drugs fate? RECORDS of the users’ experience and potential side effects will tell the story. Manage records well and the business runs efficiently. Fail to have them and your blockbuster drug is off the market with only expenses and no revenue to show for your effort. Please tell me again why I should care about investing in a Records Program in a down economy.
RECORDS LIVE

Are you kidding me.

0 comments: